Mantle P G, Macgeorge K M
Department of Biochemistry, Imperial College, London, UK.
Appl Microbiol Biotechnol. 1990 Sep;33(6):709-11. doi: 10.1007/BF00604943.
The putative role of monic acid A as a biosynthetic intermediate of the antibiotic pseudomonic acid A, providing a C17 moiety requiring only esterification with a C9 fatty acid, has been tested by administration of [14C]monic acid A early in the pseudomonic acid A idiophase of a Pseudomonas fluorescens fermentation. [14C]Monic acid A was not taken up by the cells and the pseudomonic acid A subsequently accumulated was not radiolabelled. Experimental demonstration of the biosynthetic role of monic acid A and the potential use of monate analogues in biotransformations will require unexpectedly elaborate strategies to ensure the uptake of these compounds into bacterial protoplasts. The impermeability to monic acid A explains for the first time why it is not an antibiotic.
莫尼酸A作为抗生素假单胞菌酸A生物合成中间体的假定作用,即提供仅需与C9脂肪酸酯化的C17部分,已通过在荧光假单胞菌发酵的假单胞菌酸A生长后期早期施用[14C]莫尼酸A进行了测试。细胞未摄取[14C]莫尼酸A,随后积累的假单胞菌酸A未被放射性标记。要通过实验证明莫尼酸A的生物合成作用以及莫纳特类似物在生物转化中的潜在用途,将需要出人意料的复杂策略来确保这些化合物被细菌原生质体摄取。莫尼酸A的不可渗透性首次解释了它为何不是一种抗生素。